President Joe Biden is set to sign the Congenital Heart Reauthorization Act Nov. 22, extending and expanding the CDC's National Congenital Heart Disease Research, Surveillance and Awareness Program.
Author: Elizabeth Gregerson
Jacksonville, Fla.-based Nemours Children's Health has opened a new cardiac specialty care clinic at Lewes, Del.-based Beebe Healthcare primary care facility in Selbyville, Del.
Hospitals and health systems should be bracing for an 8% and 25% increase in demand for inpatient and outpatient cardiac procedures, respectively, over the next 10 years, according to a new report from Vizient analytic company, Sg2.
The American Heart Association held its annual Scientific Sessions Nov. 16-18 in Chicago, where healthcare organizations and industry leaders presented the latest research on cardiovascular health.
Coronary artery calcium scores can accurately assess cardiovascular risk for both men and women, according to a study presented at the American Heart Association's annual Scientific Sessions Nov. 18.
Advertisement
Between 2008 and 2019, the share of cardiologists practicing in a hospital, as opposed to an independent practice, increased from 26% to 63%, according to a study published Nov. 15 in the Journal of the American College of Cardiology.
The GLP-1 tirzepatide, the active ingredient in Eli Lilly's Mounjaro, was found to reduce the risk of heart failure by 46% among individuals with obesity, according to a study published Nov. 16 in The New England Journal of Medicine and…
The GLP-1 tirzepatide, the active ingredient in Eli Lilly's Mounjaro, was found to reduce the risk of heart failure by 46% among individuals with obesity, according to a study published Nov. 16 in The New England Journal of Medicine and…
Somerville, Mass.-based Mass General Brigham has appointed Patrick Ellinor, MD, PhD, as the inaugural executive director of the system's Heart and Vascular Institute.
Surgeons at Cincinnati-based The Christ Hospital performed a successful human implantation of the BiVACOR Total Artificial Heart, marking the fourth hospital in the U.S. to complete the procedure as part of the FDA's early feasibility study.